Schedule 13G ownership disclosure

ACORDA THERAPEUTICS INC

Security class unavailable · CUSIP: 00484M601

Event date: 2021-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
106,616
Percent of class
1.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-21-000194
Form type
SC 13G/A
Filer
Acorda Therapeutics, Inc.
CIK
CIK 1008848
Filed
Feb 10, 2021
Reporting period
Jan 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub